de Maat MP - Search Results

1

Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease.

Wu H, Roks AJ, Leijten FP, Garrelds IM, Musterd-Bhaggoe UM, van den Bogaerdt AJ, de Maat MP, Simoons ML, Danser AH, Oeseburg H. Wu H, et al. Among authors: de maat mp. Clin Sci (Lond). 2014 Mar;126(6):441-9. doi: 10.1042/CS20130204. Clin Sci (Lond). 2014. PMID: 24117346

2

EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease.

Simoons ML, Vos J, de Feyter PJ, Bots ML, Remme WJ, Grobbee DE, Kluft C, de Maat MP, Fox KM, Deckers JW. Simoons ML, et al. Among authors: de maat mp, de feyter pj. Eur Heart J. 1998 Sep;19 Suppl J:J56-60. Eur Heart J. 1998. PMID: 9796842 Review.

3

An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men.

Agema WR, de Maat MP, Zwinderman AH, Kastelein JJ, Rabelink TJ, van Boven AJ, Feskens EJ, Boer JM, van der Wall EE, Jukema JW. Agema WR, et al. Among authors: de maat mp. Clin Sci (Lond). 2004 Sep;107(3):255-61. doi: 10.1042/CS20030360. Clin Sci (Lond). 2004. PMID: 15068395 Clinical Trial.

4

Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy.

Brugts JJ, Danser AH, de Maat MP, den Uil CA, Boersma E, Ferrari R, Simoons ML. Brugts JJ, et al. Among authors: de maat mp. Curr Opin Cardiol. 2008 Jul;23(4):296-301. doi: 10.1097/HCO.0b013e3283007ba6. Curr Opin Cardiol. 2008. PMID: 18520711 Review.

5

Common variation in the platelet receptor P2RY12 gene is associated with residual on-clopidogrel platelet reactivity in patients undergoing elective percutaneous coronary interventions.

Rudez G, Bouman HJ, van Werkum JW, Leebeek FW, Kruit A, Ruven HJ, ten Berg JM, de Maat MP, Hackeng CM. Rudez G, et al. Among authors: de maat mp. Circ Cardiovasc Genet. 2009 Oct;2(5):515-21. doi: 10.1161/CIRCGENETICS.109.861799. Epub 2009 Jul 24. Circ Cardiovasc Genet. 2009. PMID: 20031628

6

Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.

Brugts JJ, Isaacs A, Boersma E, van Duijn CM, Uitterlinden AG, Remme W, Bertrand M, Ninomiya T, Ceconi C, Chalmers J, MacMahon S, Fox K, Ferrari R, Witteman JC, Danser AH, Simoons ML, de Maat MP. Brugts JJ, et al. Among authors: de maat mp. Eur Heart J. 2010 Aug;31(15):1854-64. doi: 10.1093/eurheartj/ehq169. Epub 2010 Jun 10. Eur Heart J. 2010. PMID: 20538738 Clinical Trial.

7

Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease.

van Schie MC, de Maat MP, Isaacs A, van Duijn CM, Deckers JW, Dippel DW, Leebeek FW. van Schie MC, et al. Among authors: de maat mp. Blood. 2011 Jan 27;117(4):1393-9. doi: 10.1182/blood-2010-03-273961. Epub 2010 Oct 12. Blood. 2011. PMID: 20940418 Free article.

8

A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals.

Brugts JJ, Isaacs A, de Maat MP, Boersma E, van Duijn CM, Akkerhuis KM, Uitterlinden AG, Witteman JC, Cambien F, Ceconi C, Remme W, Bertrand M, Ninomiya T, Harrap S, Chalmers J, Macmahon S, Fox K, Ferrari R, Simoons ML, Danser AJ. Brugts JJ, et al. Among authors: de maat mp. J Hypertens. 2011 Mar;29(3):509-19. doi: 10.1097/HJH.0b013e328341d117. J Hypertens. 2011. PMID: 21157371

9

The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention.

van Loon JE, de Jaegere PP, Ulrichts H, van Vliet HH, de Maat MP, de Groot PG, Simoons ML, Leebeek FW. van Loon JE, et al. Among authors: de maat mp, de groot pg, de jaegere pp. Thromb Haemost. 2011 Jul;106(1):165-71. doi: 10.1160/TH10-12-0804. Epub 2011 Jun 9. Thromb Haemost. 2011. PMID: 21655675

10

A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?

Verschuren JJ, Trompet S, Wessels JA, Guchelaar HJ, de Maat MP, Simoons ML, Jukema JW. Verschuren JJ, et al. Among authors: de maat mp. Eur Heart J. 2012 Jan;33(2):165-75. doi: 10.1093/eurheartj/ehr239. Epub 2011 Jul 30. Eur Heart J. 2012. PMID: 21804109 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

333 results

Search Page